cidrap.umn5d
Study examines C diff recurrence, risk factors in cancer patients
Among 547 episodes of C difficile infection documented in cancer patients in Australia and Spain, 50% were severe, and the 90 ...
Hand sanitizer doesn’t kill these viral infections
RSV, norovirus, and the flu are all on the rise again and contrary to popular belief, hand sanitizer may not work to kill all of those germs.  According to the Centers ...
Longview News-Journal18d
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
C. difficile has been identified by the Centers for Disease Control and Prevention (CDC) as an urgent public health threat, contributing to more than 80 American deaths each day. LPOXY also plans ...
Acurx Pharmaceuticals, Inc.: Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)
Acurx has now received positive written responses from the EMA (European Medicines Agency) under its Scientific Advice Procedure that the clinical, non-clinical and ...
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Highlights:New Research Collaboration with Monash University One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum ...